In summary, E. coli-induced acute lung infection aggravated dyslipidemia in mice by inhibiting PPARα related fatty acid oxidation pathway and activating SREBP-1c related lipid synthesis pathway, which resulted from the decreased phosphorylation of AMPKα. The gene discussed is SREBF1; the disease is metabolic syndrome.